结缔组织病相关间质性肺炎：对风湿病学家和肺科医生而言的一项挑战。
Connective tissue disease associated interstitial pneumonia: a challenge for both rheumatologists and pulmonologists.
作者信息
Geerts Sarah, Wuyts Wim, Langhe Ellen De, Lenaerts Jan, Yserbyt Jonas
机构信息
Department of General Practice, Catholic University Leuven, Leuven, Belgium.
Department of Pneumology, University Hospitals Leuven, Leuven, Belgium.
出版信息
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(4):326-335. doi: 10.36141/svdld.v34i4.5894. Epub 2017 Apr 28.
Abstract
Interstitial lung disease (ILD) can be either idiopathic, the result of exposure or may be associated with extrapulmonary diseases. Among the latter, connective tissue diseases (CTDs) make up the largest part. The identification, follow-up and treatment of CTD-associated ILD (CTD-ILD) are a challenge for every physician as ILD can occur before, during and after the diagnosis of CTD. Early detection of pulmonary involvement is an essential task for the treating rheumatologist and recognition of the underlying CTD can pose a challenge for the treating pulmonologist. Multidisciplinary engagement towards the patient is therefore indispensable for optimal clinical care. .
摘要
间质性肺疾病（ILD）可以是特发性的、由接触所致，或者可能与肺外疾病相关。在后者中，结缔组织病（CTD）占了最大部分。CTD相关的ILD（CTD-ILD）的识别、随访及治疗对每位医生而言都是一项挑战，因为ILD可在CTD诊断之前、期间及之后发生。对于治疗风湿科医生来说，早期发现肺部受累是一项重要任务，而识别潜在的CTD对治疗肺科医生可能构成挑战。因此，多学科协作对患者进行治疗对于实现最佳临床护理必不可少。
相似文献
1
Connective tissue disease associated interstitial pneumonia: a challenge for both rheumatologists and pulmonologists.
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(4):326-335. doi: 10.36141/svdld.v34i4.5894. Epub 2017 Apr 28.
2
Expert Opinion Guidance on the Detection of Early Connective Tissue Diseases in Interstitial Lung Disease.
Open Access Rheumatol. 2023 May 29;15:93-102. doi: 10.2147/OARRR.S401709. eCollection 2023.
3
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement.
Diagnostics (Basel). 2020 Sep 2;10(9):664. doi: 10.3390/diagnostics10090664.
4
Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.
Korean J Intern Med. 2017 Jul;32(4):600-610. doi: 10.3904/kjim.2016.212. Epub 2017 Jun 30.
5
Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
Chron Respir Dis. 2011;8(1):53-82. doi: 10.1177/1479972310393758.
6
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature.
Autoimmun Rev. 2016 Jan;15(1):61-70. doi: 10.1016/j.autrev.2015.09.003. Epub 2015 Sep 16.
7
Idiopathic interstitial pneumonias with connective tissue diseases features: A review.
Respirology. 2016 Feb;21(2):245-58. doi: 10.1111/resp.12588. Epub 2015 Jul 26.
8
Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Kaohsiung J Med Sci. 2019 Jun;35(6):365-372. doi: 10.1002/kjm2.12066. Epub 2019 Mar 26.
9
Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Chest. 2017 Jul;152(1):103-112. doi: 10.1016/j.chest.2017.03.004. Epub 2017 Mar 12.
10
Early detection of interstitial lung disease in rheumatic diseases: A joint statement from the Portuguese Pulmonology Society, the Portuguese Rheumatology Society, and the Portuguese Radiology and Nuclear Medicine Society.
Pulmonology. 2025 Dec 31;31(1):2416840. doi: 10.1016/j.pulmoe.2023.11.007. Epub 2024 Oct 25.
引用本文的文献
1
Real-world care patterns and specialist encounters of patients with systemic autoimmune rheumatic disease-related interstitial lung disease in the United States: a retrospective administrative claims database analysis.
Rheumatology (Oxford). 2025 Apr 23. doi: 10.1093/rheumatology/keaf200.
2
The bronchoalveolar lavage fluid as a marker for pulmonary fibrosis in diffuse parenchymal lung diseases.
Front Immunol. 2025 Jan 13;15:1479458. doi: 10.3389/fimmu.2024.1479458. eCollection 2024.
3
A Practical Multidisciplinary Approach to Identifying Interstitial Lung Disease in Systemic Autoimmune Rheumatic Diseases: A Clinician's Narrative Review.
Diagnostics (Basel). 2024 Nov 27;14(23):2674. doi: 10.3390/diagnostics14232674.
4
Evaluating the diagnostic and prognostic utility of serial KL-6 measurements in connective tissue disease patients at risk for interstitial lung disease: correlations with pulmonary function tests and high-resolution computed tomography.
BMC Pulm Med. 2024 Dec 5;24(1):603. doi: 10.1186/s12890-024-03264-7.
5
The Role of CX3CL1 and ADAM17 in Pathogenesis of Diffuse Parenchymal Lung Diseases.
Diagnostics (Basel). 2021 Jun 11;11(6):1074. doi: 10.3390/diagnostics11061074.
6
CT Findings in Pulmonary and Abdominal Sarcoidosis. Implications for Diagnosis and Classification.
J Clin Med. 2020 Sep 20;9(9):3028. doi: 10.3390/jcm9093028.
本文引用的文献
1
Surgical Lung Biopsy for Interstitial Lung Diseases.
Chest. 2017 May;151(5):1131-1140. doi: 10.1016/j.chest.2016.06.019. Epub 2016 Jul 26.
2
First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value.
Lung. 2016 Oct;194(5):739-43. doi: 10.1007/s00408-016-9912-1. Epub 2016 Jul 4.
3
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.
Lancet. 2016 Jun 25;387(10038):2630-2640. doi: 10.1016/S0140-6736(16)00232-4. Epub 2016 May 5.
4
Characterisation of patients with interstitial pneumonia with autoimmune features.
Eur Respir J. 2016 Jun;47(6):1767-75. doi: 10.1183/13993003.01565-2015. Epub 2016 Apr 21.
5
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials.
Respir Med. 2016 Apr;113:74-9. doi: 10.1016/j.rmed.2016.02.001. Epub 2016 Feb 3.
6
Invasive diagnostic techniques in idiopathic interstitial pneumonias.
Respirology. 2016 Jan;21(1):44-50. doi: 10.1111/resp.12694.
7
State of the art in the diagnosis and management of interstitial lung disease.
Clujul Med. 2015;88(2):116-23. doi: 10.15386/cjmed-457. Epub 2015 Apr 15.
8
Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis.
Clin Med Insights Circ Respir Pulm Med. 2015 Sep 8;9(Suppl 1):41-9. doi: 10.4137/CCRPM.S23288. eCollection 2015.
9
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature.
Autoimmun Rev. 2016 Jan;15(1):61-70. doi: 10.1016/j.autrev.2015.09.003. Epub 2015 Sep 16.
10
Interstitial lung disease evaluation: detecting connective tissue disease.
Respiration. 2015;90(3):177-84. doi: 10.1159/000440665. Epub 2015 Sep 8.
Zotero 插件